Liver Cirrhosis, Experimental
Showing 1 - 25 of >10,000
Hepatic Cirrhosis, Liver Fibrosis Trial in San Antonio (BMS-986263, Placebo)
Completed
- Hepatic Cirrhosis
- Liver Fibrosis
- BMS-986263
- Placebo
-
San Antonio, TexasThe Texas Liver Institute
Feb 3, 2022
Liver Cirrhosis, Liver Trial (Sequential Adult Left Lateral Liver Transplantation)
Not yet recruiting
- Liver Cirrhosis
- Liver
- Sequential Adult Left Lateral Liver Transplantation
- (no location specified)
Nov 22, 2023
Metabolic Dysfunction-associated Fatty Liver Disease, Cirrhosis Trial (Pioglitazone metformin tablets, Other drugs, Drug-free)
Not yet recruiting
- Metabolic Dysfunction-associated Fatty Liver Disease
- Cirrhosis
- Pioglitazone metformin tablets
- +2 more
- (no location specified)
Nov 15, 2023
HCC, Liver Cirrhosis Trial (sequential adult left lateral lobe liver transplantation (SALT))
Not yet recruiting
- HCC
- Liver Cirrhosis
- sequential adult left lateral lobe liver transplantation (SALT)
- (no location specified)
Oct 3, 2023
Hepatic Osteodystrophy, Liver Cirrhosis Trial in New Delhi (Ibandronate, Calcium, Vitamin D3)
Not yet recruiting
- Hepatic Osteodystrophy
- Liver Cirrhosis
- Ibandronate
- +2 more
-
New Delhi, Delhi, IndiaInstitute of Liver & Biliary Sciences (ILBS)
Aug 28, 2023
Liver Cirrhosis, Liver Transplant; Complications, Physical Inactivity Trial in Groningen (Bimodal lifestyle program)
Not yet recruiting
- Liver Cirrhosis
- +2 more
- Bimodal lifestyle program
-
Groningen, NetherlandsUniversity Medical Center Groningen
May 9, 2023
Decompensated Cirrhosis Trial (Isomaltooligosaccharides (IMO))
Not yet recruiting
- Decompensated Cirrhosis
- Isomaltooligosaccharides (IMO)
- (no location specified)
Nov 12, 2023
Liver Cirrhosis Trial in Bunkyo-Ku (Foscenvivint)
Not yet recruiting
- Liver Cirrhosis
-
Bunkyo-Ku, Tokyo, JapanTokyo Metropolitan Komagome Hospital
Nov 29, 2023
Decompensated Cirrhosis Trial in Shanghai (Low-dose of Rifaximin, Conventional dose of Rifaximin)
Recruiting
- Decompensated Cirrhosis
- Low-dose of Rifaximin
- Conventional dose of Rifaximin
-
Shanghai, ChinaShanghai East Hospital
May 16, 2023
Liver Cirrhosis Trial in New Delhi (ROTEM, Thromboelastography)
Not yet recruiting
- Liver Cirrhosis
- ROTEM
- Thromboelastography
-
New Delhi, Delhi, IndiaDr Saurav Paul
Nov 22, 2023
Hyperammonemia Trial in Changchun (TNP-2092 capsules, TNP-2092 capsules)
Completed
- Hyperammonemia
- TNP-2092 placebo capsules
- TNP-2092 capsules
-
Changchun, Jilin, ChinaThe First Hospital of Jilin University
Nov 13, 2023
Decompensated Liver Cirrhosis Trial in Tehran (MSC-derived exosomes)
Recruiting
- Decompensated Liver Cirrhosis
- MSC-derived exosomes
-
Tehran, Iran, Islamic Republic ofResearch Institute of Gastroenterology & Liver Diseases
May 12, 2023
Liver Cirrhosis Trial (Apixaban 5 MG [Eliquis], Edoxaban 60 MG [Lixiana])
Not yet recruiting
- Liver Cirrhosis
- Apixaban 5 MG [Eliquis]
- Edoxaban 60 MG [Lixiana]
- (no location specified)
May 19, 2023
Cirrhosis, Liver, End Stage Liver DIsease, Symptoms and Signs Trial in Philadelphia (LiverWatch Intervention)
Not yet recruiting
- Cirrhosis, Liver
- +4 more
- LiverWatch Intervention
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Nov 13, 2023
Liver Cirrhosis, Non-Alcoholic Fatty Liver Disease, Hepatocellular Carcinoma Trial in Roma (Handgrip strength test, total body
Recruiting
- Liver Cirrhosis
- +2 more
- Handgrip strength test
- +2 more
-
Roma, RM, ItalyCEMAD
Oct 20, 2023
Decompensated Cirrhosis Trial in New Delhi (Albumin, Standard of Care)
Not yet recruiting
- Decompensated Cirrhosis
- Albumin
- Standard of Care
-
New Delhi, Delhi, IndiaInstitute of Liver & Biliary Sciences
Jun 29, 2023
Liver Transplantation in CirrHosis and Severe Acute-on-Chronic
Recruiting
- Liver Diseases
- +3 more
- Observational Protocol
-
Los Angeles, California
- +104 more
Dec 1, 2022
Cirrhosis, Liver Trial (Epigallocatechin gallate (EGCG), Placebo)
Not yet recruiting
- Cirrhosis, Liver
- Epigallocatechin gallate (EGCG)
- Placebo
- (no location specified)
Aug 27, 2023
Liver Cirrhosis Trial in New Delhi (drug, biological, other)
Not yet recruiting
- Liver Cirrhosis
- Midodrine
- +2 more
-
New Delhi, Delhi, IndiaInstitute of Liver & Biliary Sciences (ILBS)
Oct 13, 2023
Cirrhosis, Liver Trial in Cleveland (Endurance Training 3 times per week, Resistance Exercise, Standard of Care)
Recruiting
- Cirrhosis, Liver
- Endurance Training 3 times per week
- +2 more
-
Cleveland, OhioCleveland Clinic
Aug 8, 2023
Liver Cirrhosis, Acute on Chronic Liver Failure Trial in New Delhi (Relaxed Rotational Thromboelastometry, Standard Coagulation
Not yet recruiting
- Liver Cirrhosis
- Acute on Chronic Liver Failure
- Relaxed Rotational Thromboelastometry
- Standard Coagulation Tests
-
New Delhi, Delhi, IndiaInstitute of Liver & Biliary Sciences
Jan 6, 2023
Advanced Liver Fibrosis, Liver Cirrhosis Trial in Munich, Bucharest, Bratislava (ALE.F02, Placebo)
Recruiting
- Advanced Liver Fibrosis
- Liver Cirrhosis
- ALE.F02
- Placebo
-
Munich, Germany
- +2 more
Jul 10, 2023
Liver Cirrhosis Trial (Platelet Concentrate, Prothrombin Complex Concentrate, Restricitve Use)
Not yet recruiting
- Liver Cirrhosis
- Platelet Concentrate
- +2 more
- (no location specified)
Dec 28, 2022
Mobile Health, Liver Cirrhosis, Patient Activation Trial (ReLiver-N App)
Not yet recruiting
- Mobile Health
- +2 more
- ReLiver-N App
- (no location specified)
Dec 20, 2022
NAFLD Cirrhosis Trial in New Delhi (Dapagliflozin, Standard of Care)
Not yet recruiting
- NAFLD Cirrhosis
- Dapagliflozin
- Standard of Care
-
New Delhi, Delhi, IndiaInstitute of Liver & Biliary Sciences
May 5, 2023